Home
Company
Products
Community
News
Employment
Links
Who we are
Executive team
History
Divisions
Corporate US website
Investors
Suppliers
Healthcare Professionals
Search
Site map
Contact us
Legal notice
Privacy policy
Home
•
Company
•
History
•
Français
2006
In June, Health Canada issued a Notice of Compliance (NOC) for OrenciaTM (abatacept) for the treatment of rheumatoid arthritis (RA) as well as BaracludeTM (entecavir) for the treatment of chronic hepatitis B infection.
